Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (NYSE: PBH) develops, manufactures, markets, sells and distributes over-the-counter health and personal care products to retailers and e-commerce channels in North America, Australia and other international markets. Its customers include mass merchandisers, drug and food retailers,… From the company’s description.
Over the twelve months to Sep 30, 2026, Prestige Consumer Healthcare Inc. reported revenue of $1.17B, up 5.1% from a year earlier, and net income of $155.10M. Its operating margin was 25.0%, and operations generated $229.78M in cash. In fiscal 2025, it reported revenue of $1.09B, down 4.3% from fiscal 2024, and net income of $190.30M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Prestige Consumer Healthcare Inc. does
In the company’s own words
Prestige Consumer Healthcare Inc. (NYSE: PBH) develops, manufactures, markets, sells and distributes over-the-counter health and personal care products to retailers and e-commerce channels in North America, Australia and other international markets. Its customers include mass merchandisers, drug and food retailers, dollar, convenience and club stores, and online sellers. The company operates through North American OTC Healthcare and International OTC Healthcare, which accounted for 83.9% and 16.1% of fiscal 2026 net revenue, respectively. Its portfolio includes pain relief, cough and cold, eye care, gastrointestinal, dermatological, oral care and women’s health products, with brands such as BC, Clear Eyes, Compound W, Dramamine, Fleet, Gaviscon, Monistat, Summer’s Eve, Fess and Hydralyte. In fiscal 2026, approximately 83.5% of revenue came from its major brands, and the company had approximately 890 employees as of March 31, 2026. Prestige was formerly named Prestige Brands Holdings and changed its name in 2018. Its website is www.prestigebrands.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- TARRYTOWN, NY
- Fiscal year end
- March
- CIK
- 1295947
- SIC
- 2834
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Prestige Consumer Healthcare Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Prestige Consumer Healthcare Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Prestige Consumer Healthcare Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Prestige Consumer Healthcare Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Prestige Consumer Healthcare Inc.'s last four quarterly filings that the numbers alone won't show?”